On February 24, 2023, the United States Drug Enforcement Administration (“DEA”) announced proposed permanent rules (the Telemedicine Controlled Substance Proposed Rule and the Telemedicine Buprenorphine Proposed Rule —...more
Much has been written about the substantial increase in the utilization of telehealth services during the COVID-19 Public Health Emergency (“PHE”), including the 28 million Medicare beneficiaries who received telehealth...more